anmelden
NYSE International 100
11.162,78
PKT
+1,05
PKT
+0,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.09.22 | Unilever Buy | Jefferies & Company Inc. | |
| 27.09.22 | GSK Equal Weight | Barclays Capital | |
| 27.09.22 | Unilever Sector Perform | RBC Capital Markets | |
| 27.09.22 | Philips Underweight | JP Morgan Chase & Co. | |
| 27.09.22 | Siemens Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.09.22 | TotalEnergies Outperform | Credit Suisse Group | |
| 26.09.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 26.09.22 | Eni Overweight | JP Morgan Chase & Co. | |
| 26.09.22 | TotalEnergies Sector Perform | RBC Capital Markets | |
| 26.09.22 | Unilever Sector Perform | RBC Capital Markets | |
| 26.09.22 | Unilever Underweight | JP Morgan Chase & Co. | |
| 26.09.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 26.09.22 | TotalEnergies Buy | UBS AG | |
| 26.09.22 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 26.09.22 | SAP Buy | Jefferies & Company Inc. | |
| 26.09.22 | Novartis Neutral | UBS AG | |
| 26.09.22 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.09.22 | Unilever Outperform | Bernstein Research | |
| 26.09.22 | TotalEnergies Overweight | JP Morgan Chase & Co. | |
| 26.09.22 | BP Neutral | JP Morgan Chase & Co. | |
| 23.09.22 | Novartis Sell | Deutsche Bank AG | |
| 23.09.22 | BBVA Buy | Deutsche Bank AG | |
| 23.09.22 | TotalEnergies Buy | Jefferies & Company Inc. | |
| 23.09.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 23.09.22 | Eni Buy | Jefferies & Company Inc. | |
| 23.09.22 | BP Hold | Jefferies & Company Inc. | |
| 23.09.22 | Deutsche Telekom Outperform | Bernstein Research | |
| 23.09.22 | UBS Neutral | UBS AG | |
| 23.09.22 | BBVA Buy | UBS AG | |
| 23.09.22 | BBVA Neutral | JP Morgan Chase & Co. | |
| 23.09.22 | Novartis Underweight | Barclays Capital | |
| 23.09.22 | Santander Neutral | JP Morgan Chase & Co. | |
| 23.09.22 | ING Group Buy | Goldman Sachs Group Inc. | |
| 23.09.22 | Santander Buy | Goldman Sachs Group Inc. | |
| 23.09.22 | Deutsche Bank Buy | Goldman Sachs Group Inc. | |
| 23.09.22 | Allianz Buy | Goldman Sachs Group Inc. | |
| 23.09.22 | Prudential Overweight | JP Morgan Chase & Co. | |
| 23.09.22 | Novartis Underperform | Credit Suisse Group | |
| 23.09.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.09.22 | BBVA Outperform | RBC Capital Markets |
